Skip to content
Disclosery

MWG Management Ltd.

Follow

13F filer, CIK 1845151, Washington, DC

MWG Management Ltd. reported $90,299,754 across 3 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-010641

Period
2024-09-30
Reported value
$90.3M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0000950123-24-010641, largest first. % of portfolio is the value over $90,299,754, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,346,934 shares; 2024Q1: 2,346,934 shares; 2024Q2: 2,266,934 shares; 2024Q3: 2,266,934 shares 2,266,934$55.5M61.51%0Timeline
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 20,162,332 shares; 2024Q1: 20,162,332 shares; 2024Q2: 20,162,332 shares; 2024Q3: 20,162,332 shares 20,162,332$27.8M30.81%0
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,792,210 shares; 2024Q1: 1,792,210 shares; 2024Q2: 1,792,210 shares; 2024Q3: 1,792,210 shares 1,792,210$6.94M7.68%0Timeline

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-24-010641 base2024-11-08acceptance time not in the bulk data set